Abstract:The regulation of platelet function by pharmacological agents that modulate platelet signaling has proven to be a positive approach to the prevention of thrombosis. Ruthenium complexes are fascinating for the development of new drugs, as they possess numerous chemical and biological properties. The present study aims to evaluate the structure-activity relationship (SAR) of newly synthesized ruthenium (II) complexes, TQ-1, TQ-2 and TQ-3 in agonists-induced washed human platelets. Silica gel column chromatography, aggregometry, immunoblotting, NMR, and X-ray analyses were performed in this study. Of the three tested compounds, TQ-3 showed a concentration (1-5 μM) dependent inhibitory effect on platelet aggregation induced by collagen (1 μg/mL) and thrombin (0.01 U/mL) in washed human platelets; however, TQ-1 and TQ-2 had no response even at 250 μM of collagen and thrombin-induced aggregation. TQ-3 was effective with inhibiting collagen-induced ATP release, calcium mobilization ([Ca2+]i) and P-selectin expression without cytotoxicity. Moreover, TQ-3 significantly abolished collagen-induced Lyn-Fyn-Syk, Akt-JNK and p38 mitogen-activated protein kinases (p38 MAPKs) phosphorylation. The compound TQ-3 containing an electron donating amino group with two phenyl groups of the quinoline core could be accounted for by its hydrophobicity and this nature might be the reason for the noted antiplatelet effects of TQ-3. The present results provide a molecular basis for the inhibition by TQ-3 in collagen-induced platelet aggregation, through the suppression of multiple machineries of the signaling pathway. These results may suggest that TQ-3 can be considered a potential agent for the treatment of vascular diseases.

Synthesis and Evaluation of Antiplatelet Activity of Trihydroxychalcone Derivatives

Synthesis and Evaluation of Antiplatelet Activity of Trihydroxychalcone Derivatives.

Design, Synthesis and Antiplatelet Evaluation of Tetramethylpyrazine/chalcone Hybrids

Synthesis and Evaluation of Antiinflammatory Activity of Substituted Chalcone Derivatives

Synthesis and Evaluation of Chalcone Derivatives as Prospective Anti-Inflammatory Compounds

Synthesis and Biological Evaluation of Chalcone Derivatives Containing Aminoguanidine or Acylhydrazone Moieties

Synthesis of 3,15-Disuccinate-12-coumarin Substituted Andrographolide Derivatives and Their Antiplatelet Aggregation Activities in Vitro

Synthesis of 2,3‐disubstituted 1,4‐naphthoquinones As Antiplatelet Agents

Structure-Antiplatelet Activity Relationships of Novel Ruthenium (II) Complexes: Investigation of Its Molecular Targets

Evaluation and Discovery of Novel Synthetic Chalcone Derivatives As Anti-Inflammatory Agents.

Synthesis, biological evaluation and mechanism study of chalcone analogues as novel anti-cancer agents

Synthesis and Biological Evaluation of Amino Chalcone Derivatives as Antiproliferative Agents

Synthesis and biological evaluation of the novel antitumor agent 3'-monosubstituted chalcone derivatives

Synthesis and Antiplatelet, Antiinflammatory, and Antiallergic Activities of Substituted 3-Chloro-5,8-dimethoxy-1,4-naphthoquinone and Related Compounds

Synthesis and Evaluation in vitro of Dihydrothiophenopyridine-Chalcone Derivatives as Anticancer Activity Agents

Structure–activity Relationship Investigation of Coumarin–chalcone Hybrids with Diverse Side-Chains As Acetylcholinesterase and Butyrylcholinesterase Inhibitors

Synthesis and antiplatelet aggregation activities of prasugrel derivatives

Synthesis and evaluation of L-quebrachitol derivatives against platelet aggregation

Studies On The Synthesis Of Novel Chalcone And Biological Activity

Synthesis and Antithrombotic Activity of 3-Aryl-1,2,3,4-oxatriazole-5-imine-coupled Aspirin

Design, Synthesis and Biological Evaluation of Novel Trimethylpyrazine-2-carbonyloxy-cinnamic Acids As Potent Cardiovascular Agents